16th ANNUAL EARLY HEARING DETECTION & INTERVENTION MEETING
February 26-28, 2017 • Atlanta, GA

<< BACK TO AGENDA

2/28/2017  |   9:40 AM - 10:10 AM   |  Hearing Targeted Congenital Cytomegalovirus Screening as Part of a Universal Newborn Hearing Screening Program   |  Grand Hall A

Hearing Targeted Congenital Cytomegalovirus Screening as Part of a Universal Newborn Hearing Screening Program

Infants with congenital cytomegalovirus (cCMV) can be symptomatic with sequelae present at birth, or asymptomatic. Otherwise asymptomatic infants may present with decreased hearing, and not pass hearing screening; delayed onset or progressive hearing difficulties is evident in some. The Joint Committee on Infant Hearing (2007) recommends that infants with hearing loss receive testing for cCMV. To be confident infants who are positive for CMV were congenitally infected, testing must occur before 3 weeks of age. The impact of cCMV on infants and families has led to interest in establishing public health policy to provide education, public awareness and screening for cCMV. Many states have either enacted legislation supporting cCMV initiatives or are in the process of doing so. Since some otherwise asymptomatic cCMV infants may present with congenital hearing difficulties, in lieu of universal cCMV screening, screening for cCMV in infants who do not pass newborn hearing screening has been implemented by some hospitals and statewide in some states. This presentation will provide an overview of cCMV, sequelae, screening techniques and treatment options. Further, implementation of hearing targeted cCMV screening (HT-cCMV) at a large county hospital and in a statewide program will be discussed. A multidisciplinary team from administration, neonatology, nurse management, pediatric nurse practitioners, and audiology collaborated to plan and initiate universal newborn hearing and HT-cCMV screening at Parkland Hospital, Dallas, Texas in 1999. Results indicate that approximately 6% of infants that did not pass UNHS and had a confirmed hearing deficit were positive for cCMV. Utah implemented statewide HT-cCMV screening in 2013. Our 2 year experience indicates improvement in time to diagnose hearing in all children since the mandate was enacted. Extrapolating data from the Utah statewide program, if implemented nationwide, approximately 1200 newborns could be diagnosed with cCMV using this screening approach in the US annually.

  • Understand why early CMV detection is beneficial to infants and families.
  • Learn about current state-wide legislative cCMV intiatives
  • Develop strategies to implement HT-cCMV screening

Presentation:
15804_5764AngelaShoup.pdf

Handouts:
Handout is not Available

Transcripts:
5764.docx


Presenters/Authors

Angela Shoup (), UT Southwestern Medical Center, Dallas, Texas, angela.shoup@utsouthwestern.edu;
Angela Shoup, Ph.D. is an Associate Professor in the Department of Otolaryngology – Head and Neck Surgery at the University of Texas Southwestern Medical Center where she also serves as Director of the Division of Communicative and Vestibular Disorders. Dr. Shoup is affiliated with the Aston Ambulatory Care Center, Parkland Hospital and Childrens Health. Dr. Shoup has published articles and textbook chapters on audiologic procedures, including newborn hearing screening, and implantable hearing aids. She has been an invited speaker at national and international meetings. She served as President of the Texas Academy of Audiology, Chair of the Ethical Practices Committee for the American Academy of Audiology, and Chair of the Board of Trustees for the American Academy of Audiology Foundation.

ASHA DISCLOSURE:

Financial - No relevant financial relationship exist.

Nonfinancial - No relevant nonfinancial relationship exist.


Albert Park (), University of Utah, albert.park@hsc.utah.edu;
Albert Park, MD, serves as the section chief of pediatric otolaryngology and professor within the Department of Surgery and the Department of Pediatrics at the University of Utah. Dr. Park obtained his MD at the Washington University School of Medicine. He then completed his residency training at Loyola University Medical Center and pediatric otolaryngology fellowship training at the Hospital for Sick Children in Toronto, Canada. His primary research interest focuses on understanding the pathophysiology of congenital cytomegalovirus (CMV) induced hearing loss and developing novel assays for diagnosis.

ASHA DISCLOSURE:

Financial - Receives Grants for Independent contractor from Triolologic Society .   Receives Grants for Independent contractor from Triologic Society.   Receives Ownership interest for Other activities from Carbylan, Inc.   Receives Ownership interest for Other activities from Carbylan, Inc.   Receives Ownership interest for Other activities from Otonomy Inc. .   Receives Ownership interest for Other activities from Otonomy Inc. .   Receives Ownership interest for Other activities from Transit Scientific, LLC.   Receives Ownership interest for Other activities from Transit Scientific, LLC.  

Nonfinancial - No relevant nonfinancial relationship exist.


Kris Owen (), UT Southwestern Medical Center at Dallas, Texas, kris.owen@childrens.com;
Kris Owen, Au.D. is a pediatric audiologist that serves as coordinator of the Universal Newborn Hearing Screening Program at Parkland Hospital. She also provides diagnostic pediatric assessments at Childrens Medical Center. Her research interests focus on universal newborn hearing screening, CMV, and pediatric diagnostic assessment.

ASHA DISCLOSURE:

Financial - No relevant financial relationship exist.

Nonfinancial - No relevant nonfinancial relationship exist.